Discrepancies in testing recommendations for Clostridium difficile infection: Updated review favors amplification test systems

Expert Review of Molecular Diagnostics

Volumn 12, Issue 3, 2012, Pages 223-226

  Chapin, Kimberle ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

CDI; Clostridium difficile; EIA; GDH; guidelines; NAAT

Indexed keywords

BACTERIAL TOXIN; GLUTAMATE DEHYDROGENASE;

BACTERIAL GROWTH; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; EDITORIAL; ENZYME IMMUNOASSAY; HOSPITAL COST; HUMAN; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CYTOTOXINS; ENTEROTOXINS; GLUTAMATE DEHYDROGENASE; GUIDELINES AS TOPIC; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84859393491     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.13     Document Type: Editorial

References (20)

1. Dubberke ER, Wertheimer A. Review of current literature on the economic burden of Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 30(1), 57-66 (2009).
2. Doing K, Hintz M. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples. Diagnostic Microbiol. Infect. Dis. 72, 8-13 (2012).
3. Tenover F, Baron E, Peterson L, Persing D. Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty? J. Mol. Diagnostics 12(6), 573-582 (2010).
4. Lyras D, O'Connor J, Howarth P et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458(7242), 1176-1179 (2009).
5. Voth D, Ballard J. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18(2), 247-263 (2005).
6. Bacci S, Molbak K, Kjeldsen MK, Olsen KEP. Binary toxin and death after Clostridium difficile infection. Emerg. Infect. Dis. 17(6), 976-982 (2011).
7. Cohen S, Gerding D, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for healthcare epidemiology of America (SHEA) and the Infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31(5), 431-455 (2010).
8. Crobach M, Dekkers O, Wilcox M, Kuiper E. European society of clinical microbiology and infectious diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin. Microbiol. Infect. 15(12), 1053-1066 (2009).
9. Boyanton BLJ, Sural P, Loomis C et al. Loop-mediated isothermal amplification compared to real-time pcr and enzyme immunoassay for toxigenic C. difficile detection. J. Clin. Microbiol. 50(3), 640-645 (2011).
10. Chapin KC, Dickenson RA, Wu F, Andrea SB. Comparison of five assays for detection of Clostridium difficile toxin. J. Mol. Diagnostics 13(4), 395-500 (2011).
11. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47(10), 3211-3217 (2009).
12. Peterson L, Mehta MS, Patel PA et al. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am. J. Clin. Pathol. 136(3), 372-380 (2011).
13. Peterson L, Robicsek A. Does my patient have Clostridium difficile infection? Ann. Inter. Med. 151(3), 176-179 (2009).
14. Larson A, Fung A, Fang F. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 48(1), 124-130 (2010).
15. Novak-Weekley S, Marlowe E, Miller J et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J. Clin. Microbiol. 48(3), 889-893 (2010).
16. Tenover F, Novak-Weekley S, Woods C et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48(10), 3719-3724 (2010).
17. Sharp S, Ruden L, Pohl J, Hatcher P, Jayne L, Ivie W. Evaluation of the C. Diff Quik Chek complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48(6), 2082-2086. (2010).
18. Wilcox M, Planche T, Fang F, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48(12), 4347-4353 (2010).
19. Alcala L, Sanchez-Cambronero L, Catalan M et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J. Clin. Microbiol. 46(11), 3833-3835 (2008).
20. American Society for Microbiology. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile. www.asm.org